A tumor-blocking protein may be key in developing deadly form of pancreatic cancer
 

A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 ? which normally applies the brakes on a cancer-causing gene ? is missing in an aggressive form of pancreatic cancer.

More...